
multiple sclerosis, MS, Tysabri, natalizumab, progressive multifocal leukoencephalopathy, PML
multiple sclerosis, MS, Tysabri, natalizumab, progressive multifocal leukoencephalopathy, PML
The most comprehensive evidence-based recommendations for preventing a second stroke have been released by the American Heart Association and the American Stroke Association's Stroke Council.1 In contrast with previous clinical practice guidelines, the new guidelines tie transient ischemic attack (TIA) with stroke, said Ralph Sacco, MD, chair of the American Stroke Association's Secondary Stroke Prevention Guidelines Committee.
When Medicare enrollees became entitled to the first-ever outpatient prescription drug benefit in January, the program was introduced with great fanfare and with the mission of Medicare Part D programs to make drugs more affordable for the elderly and disabled. The Medicare drug benefit issue, however, has been mired in controversy since Congress took it up years ago.
Multiple sclerosis, McDonald Diagnostic Criteria
Parkinson disease, Disease management
cancerpain,neuro-oncology
"Chemobrain," a term coined by patients in breast cancer support groups to describe cognitive impairment associated with chemotherapy, is becoming a subject of research.
All clinical trial sponsors will be required to register all publicly and privately sponsored clinical trials with the existing government clinical trials registry, www.clinicaltrials.gov, before the first patient is enrolled in the trial.
Published: November 1st 2005 | Updated:
Published: July 1st 2005 | Updated:
Published: April 5th 2006 | Updated:
Published: August 1st 2005 | Updated:
Published: April 1st 2006 | Updated:
Published: January 1st 2006 | Updated: